Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200mg twice daily to nevirapine extended release 400mg once daily (TRANxITION)
- Publication date
- 1 January 2012
- Publisher
- Health Sciences Research Commons